Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Mark H. Schutta, MD

Mark H. Schutta, MD Physician

Medical Director, Penn Rodebaugh Diabetes Center G. Clayton Kyle Associate Professor in Diabetes

Dr. Schutta is employed by Penn Medicine.

About Dr. Mark H. Schutta

Recognized by America's Top Doctors, 2012-14

Recognized in Philadelphia magazine's annual Top Docs issue, 2002, and 2013 - 2017

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties


  • Diabetes, Endocrinology and Metabolism

Programs & Centers:

Board Certification:

  • Endocrinology, Diabetes, & Metabolism, 2002

Clinical Expertise:

  • Low Blood Sugar (Hypoglycemia)

Description of Clinical Expertise

Dr. Schutta specializes in the diagnosis and treatment of diabetes and hypoglycemia disorders. Dr. Schutta predominantly cares for patients with pre-diabetes, type 1 and type 2 diabetes as well as post-transplantation diabetes. He has a particular interest in diabetes prevention and in-patient management of diabetes and hyperglycemia. Dr. Schutta presently serves as Medical Director of the Penn Rodebaugh Diabetes Center.

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Jefferson Medical College
Residency: Thomas Jefferson University Hospital
Fellowship: Hospital of the University of Pennsylvania


American Diabetes Association, Eastern Pennsylvania and Delaware Chapter, Community Leadership Board April 2014 to present. , Local American Diabetes Association, National Philadelphia College of Physicians , Local The Endocrine Society , National Wawa Corporation, National

Hospital Affiliation

Dr. Schutta is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.


Description of Research Expertise:

Dr. Schutta is involved in several research areas including the effects of bariatric surgery on diabetes remission and the association between coronary calcification and cardiovascular risk in type 2 diabetic patients.

Selected Publications:

Martin SS., Qasim AN., Mehta NN., Wolfe M., Terembula K., Schwartz S., Iqbal N., Schutta M., Bagheri R.: Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites Diabetes 58 : 1887-1892,2009.

Diabetes and Hypertension Journal of Cardiometabolic Syndrome : 124-130,2007.

Rickels MR., Schutta MH., Mueller R., Kapoor S., Markmann JF., Naji A.: Glycemic Thresholds for Activation of Counterregulatory Hormone and Symptom Responses in Islet Transplant Recipients J Clin Endocrinol Metab : 2006.

Cardillo S.: Repaglinide Induced Hypoglycemia in a Patient with Cystic Fibrosis-Related Diabetes Mellitus Endo Trends 13 (4): 6-7,2006.

Rickels MR., Schutta MH., Markmann JF., Barker CF., Naji A.: Beta-cell function following human islet transplantation for type 1 diabetes Diabetes 54 (1): 100-6,2005.

Rickels MR., Schutta MH., Markmann JF., Barker CF., Naji A.: Beta-Cell Function Following Human Islet Transplantation for Type 1 Diabetes Mellitus: Preliminary Results Oral presentation at the American Diabetes Association Meeting : 2007.

Reilly MP., Iqbal N., Schutta M., Wolfe ML., Scally M., Localio AR., Rader DJ.: Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes J Clin Endocrinol Metab 89 (8): 3872-8,2004.

Academic Contact Info

Penn Rodebaugh Diabetes Center
4th Floor, Penn Tower
Hospital of the University of Pennsylvania
3400 Spruce Street

Philadelphia, PA 19104-4283
Phone: (215) 662-2468
Patient appointments: 800-789-7366 (PENN)

Related Links